A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis

Neurology

Volumn 64, Issue 7, 2005, Pages 1267-1269

  Wingerchuk, Dean M ^a   Benarroch, E E ^b   O'Brien, P C ^c   Keegan, B M ^b   Lucchinetti, C F ^b   Noseworthy, J H ^b   Weinshenker, B G ^b   Rodriguez, M ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic ^*

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; EPIGASTRIC PAIN; FATIGUE; FEMALE; HEADACHE; HUMAN; MALE; MODIFIED FATIGUE IMPACT SCALE; MULTIPLE SCLEROSIS; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

EID: 16844368558     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000156803.23698.9A     Document Type: Article

References (10)

1. Multiple Sclerosis Clinical Practice Guidelines: Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Washington, DC: Paralyzed Veterans Association, 1998.
2. Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000;4:1-61.
3. Wingerchuk DM, Benarroch E, Rodriguez M. Aspirin for multiple sclerosis related fatigue. Can J Neurol Sci 1997;24:161.
4. Senn, S. Cross-over trials in clinical research. West Sussex, England: John Wiley and Sons Ltd., 1993.
5. Wingerchuk DM, Noseworthy JH, Weinshenker BG. Clinical outcome measures and rating scales in multiple sclerosis trials. Mayo Clin Proc 1997;72:1070-1079.
6. Amin AR, Attur MG, Pillinger M, Abramson SB. The pleiotropic functions of aspirin: mechanisms of action. Cell Mol Life Sci 1999;56:305-312.
7. Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front Biosci 2004;9:1433-1449.
8. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321:1183-1187.
9. Schwid SR, Thornton CA, Pandya S, et al. Quantitative assessment of motor fatigue and strength in MS. Neurology 1999;53:743-750.
10. Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000;55:934-939.